Sterling Capital Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Sterling Capital Management’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.3K	Buy	+686	New	+$2.73K	﹤0.01%	2819

Other funds holding ORMP

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Sage Capital Management Stockton, New Jersey $256M AUM 29.76% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pioneer Family Office North Miami Beach, Florida $194M AUM

Sterling Capital Management's ORMP Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2026: 686 shares worth $3.3K. The stake represents ﹤0.01% of the portfolio and ranks #2819 among its holdings.

14 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

Sterling Capital Management held 686 shares of Oramed Pharmaceuticals worth $3.3K as of Q2 2026.
Oramed Pharmaceuticals was a new Sterling Capital Management position in Q2 2026.
Oramed Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2819 holding.
14 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.